People | October 05, 2023
Emmes appoints Matt Bond as CFO
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)